CV Sciences Inc (CVSI): The earnings report from this morning st...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	1099
Boards Moderated	0
Alias Born	06/07/2018

Deetew

Re: None

Wednesday, 11/07/2018 11:30:57 PM

Wednesday, November 07, 2018 11:30:57 PM

The earnings report from this morning stated:

"Our drug development program is making steady progress in advancing our proprietary lead drug candidate - CVSI-007 - which addresses the multibillion dollar smokeless tobacco use and addiction market. We continue to make progress with our pre-clinical program, anticipating filing an Investigational New Drug application in 2019. We are confident that our continued growth and profitability will allow us to initially pursue our drug development plans without the need for additional outside capital in the near term."

Could this be why they are stock-piling cash?

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CVSI News

Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM